(CIDRAP News) A committee of the Institute of Medicine (IOM) has concluded after 17 months of study that the existing anthrax vaccine is effective and "acceptably safe," but a new vaccine that requires fewer doses and that causes fewer reactions is needed.
(CIDRAP News) Three case reports from the recent anthrax outbreak published in the February 20 issue of the Journal of the American Medical Association demonstrate that even patients without obvious anthrax exposure may be at risk, pointing up the need for heightened public health surveillance and increased public awareness.
(CIDRAP News) The Centers for Disease Control and Prevention (CDC) says it will take several months to determine if women in the US military who received anthrax vaccine in the first trimester of pregnancy had a greater risk of bearing children with birth defects.
(CIDRAP News) The proposed 2003 budget for the US Department of Health and Human Services (HHS) features a 45% increase in spending for bioterrorism preparedness, with research at the National Institutes of Health (NIH) accounting for much of the increase.
(CIDRAP News) Testing has shown that anthrax found in a Federal Communications Commission (FCC) mail-processing facility in Maryland last week was a tiny amount that probably came from cross-contaminated mail, the FCC announced yesterday.
(CIDRAP News) A bioterrorist attack that caused mass casualties would very likely lead to shortages of medical resources, so preparedness planning must include a careful look at how to ration those resources fairly, an emergency medicine specialist told a conference audience in Minneapolis this week.
(CIDRAP News) Thousands of people who were potentially exposed to anthrax last fall will be interviewed over the next 8 weeks to assess the results of their postexposure antibiotic treatment, the Centers for Disease Control and Prevention (CDC) announced yesterday.
(CIDRAP News) A preliminary study linking anthrax vaccinations in pregnant women with an increased risk of birth defects in their babies has prompted the US military to step up efforts to prevent immunization of pregnant women.
(CIDRAP News) Federal health officials revealed this week that they are working on a plan to use immune globulin derived from the blood of anthrax-vaccinated military personnel for emergency treatment of patients with severe cases of inhalational anthrax, if needed.